ID   HLR-CREB
AC   CVCL_KB18
SY   PathDetect HLR-CREB
DR   Wikidata; Q54889863
RX   PubMed=11355349;
WW   https://www.chem-agilent.com/pdf/strata/800050.pdf
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene expression is under the control of a synthetic promoter containing 5 direct repeats of the 17-mer GAL4-binding site.
CC   Characteristics: Transfected with the activation domain of CREB1 fused to the yeast GAL4 DNA-binding domain.
CC   Transfected with: HGNC; 2345; CREB1 (with del 281-341).
CC   Transfected with: UniProtKB; P08659; Firefly luciferase.
CC   Transfected with: UniProtKB; P04386; Yeast GAL4 (with del 148-881).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Agilent Technologies/Stratagene; Catalog number 800065.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB15 ! HLR
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 10
//
RX   PubMed=11355349; DOI=10.2144/01305dd06;
RA   Hexdall L., Zheng C.-F.;
RT   "Stable luciferase reporter cell lines for signal transduction pathway
RT   readout using GAL4 fusion transactivators.";
RL   BioTechniques 30:1134-1138(2001).
//